CXCL1 and neoplasm: It had been showed that CXCR2 ligands, such as C-X-C motif chemokine (CXCL)1–3 and CXCL5–8 released from various cancer type drive neutrophil recruitment from circulation and chemotaxis toward the tumor (Sharma et al., 2013).